By Thomas Lee
FRIDLEY, Minnesota– Leptos Biomedical Inc., a start-up developing a neurostimulation device to treat obesity, is shutting down.
In a brief phone interview, CEO Hans Neisz declined to say why. The move was sudden and unexpected but had nothing to do with financing, he said.